(Q36145832)

12 August 2017

1 reference

title

Depression in chronic heart failure: novel pathophysiological mechanisms and therapeutic approaches (English)

1 reference

12 August 2017

1 reference

1 reference

chronic heart failure

1 reference

John T Parissis

1

1 reference

12 August 2017

Katerina Fountoulaki

series ordinal

2

1 reference

12 August 2017

Ioannis Paraskevaidis

series ordinal

3

1 reference

12 August 2017

Dimitrios Kremastinos

series ordinal

4

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

Expert Opinion on Investigational Drugs

12 August 2017

published in

1 reference

12 August 2017

volume

14

1 reference

12 August 2017

issue

5

1 reference

12 August 2017

page(s)

567-577

1 reference

Awareness, diagnosis, and treatment of depression

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Prevalence of depression in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Depression in hospitalized older patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

The influence of age, gender, and race on the prevalence of depression in heart failure patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Predictors of the onset of depressive symptoms in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Depression and risk of heart failure among older persons with isolated systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Usefulness of depression to predict time to combined end point of transplant or death for outpatients with advanced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Depression: are we ignoring an important comorbidity in heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Relationship between psychosocial variables and compliance in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Prognostic importance of emotional support for elderly patients hospitalized with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Social relationships and mortality in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Mechanisms and models in heart failure: A combinatorial approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Inflammatory mediators in chronic heart failure: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

A glossary of circulating cytokines in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Basic mechanisms in heart failure: the cytokine hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Tumour necrosis factor-alpha and the failing heart--pathophysiology and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Major depression and activation of the inflammatory response system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Cytokines in depression and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Cytokine-associated emotional and cognitive disturbances in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Cytokines and immune activation in systolic heart failure: the role of Type D personality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Restoring function in failing hearts: the effects of beta blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Effects of vesnarinone on peripheral circulating levels of cytokines and cytokine receptors in patients with heart failure: a report from the Vesnarinone Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Anti-tumor necrosis factor-alpha antibody limits heart failure in a transgenic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Cytokine-binding proteins: stimulating antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Quality of life, psychological and physiological changes following exercise training in patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Nonpharmacologic therapy improves functional and emotional status in congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Sertraline treatment of major depression in patients with acute MI or unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Induction of interleukin-1 beta and interleukin-1 receptor antagonist mRNA by chronic treatment with various psychotropics in widespread area of rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Exaggerated serotonin-mediated platelet reactivity as a possible link in depression and acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Short-term sertraline treatment suppresses sympathetic nervous system activity in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Negative Immunoregulatory Effects of Antidepressants Inhibition of Interferon-γ and Stimulation of Interleukin-10 Secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.567

10.1517/13543784.14.5.567

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference